MARK HELLER — Lobbyist Profile | Poliscope

MARK HELLER

Reported covered position: N/A

Filings

Clients

Firms

Years active

2004–2007

Associated filing income

$130,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
ADVANCED MEDICAL TECHNOLOGY ASSN	7	2004–2007
COOK INC/COOK GROUP	4	2004–2006
FUJIFILM MEDICAL SYSTEMS	4	2004–2006
AGILENT TECHNOLOGIES	3	2004–2006
HILLENBRAND INDUSTRIES	2	2004
MEDTRONIC	2	2004–2005

Lobbying firms

Firm	Filings	Years
WILMER CUTLER PICKERING HALE AND DORR LLP	23	2004–2007

Bills explicitly cited in this lobbyist’s assigned issues (3)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 3580

Victims Tax Fairness Act of 2003

Client: HILLENBRAND INDUSTRIES · Firm: WILMER CUTLER PICKERING HALE AND DORR LLP

Open original LDA filing ↗

Cited source text

Implementation of medical device laws (H.R. 3580). Activities related to the medical device regulatory authority of the United States Food and Drug Administration

H.R. 3580

Victims Tax Fairness Act of 2003

Client: FUJIFILM MEDICAL SYSTEMS · Firm: WILMER CUTLER PICKERING HALE AND DORR LLP

Open original LDA filing ↗

Cited source text

Implementation of medical device laws (H.R. 3580). Activities related to the medical device regulatory authority of the United States Food and Drug Administration

Original LDA source filings (23)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

ADVANCED MEDICAL TECHNOLOGY ASSN via WILMER CUTLER PICKERING HALE AND DORR LLP

2007 · mid_year · MT

Firm income: $0Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

ADVANCED MEDICAL TECHNOLOGY ASSN via WILMER CUTLER PICKERING HALE AND DORR LLP

2006 · year_end · YT

Firm income: $0Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Source: Senate LDA